Claims for Patent: 7,244,403

Summary for Patent: 7,244,403

Title:	Purification of Lutetium 177
Abstract:	Undesirable metal cation contaminants, including hafnium, can be reduced from a solution containing Lutetium-177 on a bed of an anion exchange resin. The thus purified solution can be stored and transported in a polypropylene vial, to prevent the possibility of hafnium entering the solution from a glassware wall and of Lutetium from being lost from the solution by chemically reacting with a glassware wall. The vial can be sealed with a rubber stopper which has a polytetrafluoroethylene coating facing the solution to prevent the possibility of contaminants which could interfere with later uses of the Lutetium-177 from leaching into the solution from the rubber stopper. Recipients of the Lutetium-177-containing vial can be provided with a prepackaged column of the anion exchange resin to enable such recipients to remove the hafnium which accumulated in the solution as a product of radioactive decay during shipment.
Inventor(s):	Maloney; Thomas J. (Friendswood, TX), Camp, Jr.; Arthur E. (Richmond, TX), Hernandez, Jr.; Jesse J. (Alvin, TX)
Assignee:	Iso-Tex Diagnostics, Inc. (Friedswood, TX)
Application Number:	11/408,005
Patent Claims:	1. A process for purifying a dilute HCl solution of Lutetium-177 which contains undesirable hafnium cation contaminant, said process comprising contacting said solution with a bed of an anion exchange resin under conditions to retain the hafnium cation contaminant in the bed, wherein the bed of resin forms a strong anion exchange inside a column and the contacting occurs by flowing the solution through the column, and the column is prepared for purifying the solution of Lutetium-177 by flowing an HCl solution through the column to form an HCl treated column and then flowing an NaCl solution through the HCl treated column to form an NaCl treated column. 2. A process as in claim 1 further comprising further preparing the column for purifying the solution of Lutetium-177 by flowing sterile water through the NaCl-treated column. 3. A process as in claim 2 wherein the column has an upper end and a lower end, said process further comprising injecting gas into an upper end of the column to push the solution of Lutetium 177 through the column. 4. A process as in claim 3 wherein the anion exchange resin is in powdered form. 5. A process as in claim 4 wherein the anion exchange resin comprises particles having a particle size predominantly in the range of about to 100 to about 200 mesh. 6. A process as in claim 5 wherein the anion exchange resin is strongly basic anion, 8% cross linking.

Details for Patent 7,244,403

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2039-09-22